Abstract 18020: An Analysis of Retraction Studies in the Cardiology in Last 2 Decades

• DOI: 10.1161/circ.148.suppl_1.18020
• Publication Date: 2023-12-19T08:12:47Z
• Authors: Akash Sharma; Vidusha Karavadi; Harshini Suresh; Priyali Singh; Parteek Walia; Sowntappan Balasu...; U Venkatesh
• Keywords: Impact factor

Background: False information might harm patients and increase medical care costs. For accurate rapid scientific advancement clinical care, the integrity of published biomedical literature is essential. Hence, we analyzed retracted studies in cardiology. Methodology: We adhere to STROBE checklist. This cross-sectional study utilized PubMed Embase databases identify publications from 2002-2022. The articles are retrieved for detailed analysis various characteristics, including year publication, article type, causes retraction, impact factor, number citations, author country. statistical was done by using R software. Fischer t-test 2-sample were used compare two groups. Mann-Kendall Trend Test know trend variables. P-value <0.05 considered significant. Results: search yielded 979 articles. Randomized controlled studies, experimental case-control major designs. Authors China have highest (36.1%), followed USA (22.4%) Japan (4%). most common cause retraction mistakes honest errors (24.51%); duplicate data (17.78%). From 2002 2022, there has been an insignificant with a significant decrease factor journals, time retraction. In first decade(FD, 2003-2012) second decade (SD, 2013-2023), males (68.2% FD 66.9% SD) had higher FD, USA's authors retractions (32.5%), while SD, it Chinese (46%). fewer citations than (mean difference (MD) -96.37, 95% CI -142.12 -50.62, p-value <0.001). Also, SD less (MD -9.12, 95%CI -15.52 -2.71, p-value<0.005). Conclusion: retracting cardiovascular diseases increasing. still cited, but decreasing trend.